219 related articles for article (PubMed ID: 24945800)
1. Forward genetic screening identifies a small molecule that blocks Toxoplasma gondii growth by inhibiting both host- and parasite-encoded kinases.
Brown KM; Suvorova E; Farrell A; McLain A; Dittmar A; Wiley GB; Marth G; Gaffney PM; Gubbels MJ; White M; Blader IJ
PLoS Pathog; 2014 Jun; 10(6):e1004180. PubMed ID: 24945800
[TBL] [Abstract][Full Text] [Related]
2. The Activin Receptor, Activin-Like Kinase 4, Mediates
Lis A; Wiley M; Vaughan J; Gray PC; Blader IJ
Front Cell Infect Microbiol; 2019; 9():36. PubMed ID: 30891432
[TBL] [Abstract][Full Text] [Related]
3. TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production.
Brumlik MJ; Pandeswara S; Ludwig SM; Jeansonne DP; Lacey MR; Murthy K; Daniel BJ; Wang RF; Thibodeaux SR; Church KM; Hurez V; Kious MJ; Zhang B; Alagbala A; Xia X; Curiel TJ
Exp Parasitol; 2013 Jul; 134(3):389-99. PubMed ID: 23541881
[TBL] [Abstract][Full Text] [Related]
4. siRNA Screening Identifies the Host Hexokinase 2 (HK2) Gene as an Important Hypoxia-Inducible Transcription Factor 1 (HIF-1) Target Gene in Toxoplasma gondii-Infected Cells.
Menendez MT; Teygong C; Wade K; Florimond C; Blader IJ
mBio; 2015 Jun; 6(3):e00462. PubMed ID: 26106078
[TBL] [Abstract][Full Text] [Related]
5. ROP16-Mediated Activation of STAT6 Suppresses Host Cell Reactive Oxygen Species Production, Facilitating Type III Toxoplasma gondii Growth and Survival.
Kochanowsky JA; Thomas KK; Koshy AA
mBio; 2021 Mar; 12(2):. PubMed ID: 33653884
[TBL] [Abstract][Full Text] [Related]
6. Loss of the Conserved Alveolate Kinase MAPK2 Decouples
Hu X; O'Shaughnessy WJ; Beraki TG; Reese ML
mBio; 2020 Nov; 11(6):. PubMed ID: 33173004
[TBL] [Abstract][Full Text] [Related]
7. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii expresses two mitogen-activated protein kinase genes that represent distinct protozoan subfamilies.
Lacey MR; Brumlik MJ; Yenni RE; Burow ME; Curiel TJ
J Mol Evol; 2007 Jan; 64(1):4-14. PubMed ID: 17160647
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations in TgMAPK1 of Toxoplasma gondii conferring resistance to 1NM-PP1.
Sugi T; Kobayashi K; Takemae H; Gong H; Ishiwa A; Murakoshi F; Recuenco FC; Iwanaga T; Horimoto T; Akashi H; Kato K
Int J Parasitol Drugs Drug Resist; 2013 Dec; 3():93-101. PubMed ID: 24533298
[TBL] [Abstract][Full Text] [Related]
10. Serum response factor regulates immediate early host gene expression in Toxoplasma gondii-infected host cells.
Wiley M; Teygong C; Phelps E; Radke J; Blader IJ
PLoS One; 2011 Mar; 6(3):e18335. PubMed ID: 21479245
[TBL] [Abstract][Full Text] [Related]
11. Impact of Engineered Expression of Mitochondrial Association Factor 1b on
English ED; Boyle JP
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181
[TBL] [Abstract][Full Text] [Related]
12. The
Glausen TG; Carrillo GL; Jin RM; Boyle JP; Saeij JPJ; Wohlfert EA; Fox MA; Blader IJ
mBio; 2021 Jun; 12(3):e0133121. PubMed ID: 34154412
[TBL] [Abstract][Full Text] [Related]
13. Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development.
Radke JR; Donald RG; Eibs A; Jerome ME; Behnke MS; Liberator P; White MW
PLoS Pathog; 2006 Oct; 2(10):e105. PubMed ID: 17069459
[TBL] [Abstract][Full Text] [Related]
14. Pyridinylimidazole p38 mitogen-activated protein kinase inhibitors block intracellular Toxoplasma gondii replication.
Wei S; Marches F; Daniel B; Sonda S; Heidenreich K; Curiel T
Int J Parasitol; 2002 Jul; 32(8):969-77. PubMed ID: 12076626
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii.
Brumlik MJ; Wei S; Finstad K; Nesbit J; Hyman LE; Lacey M; Burow ME; Curiel TJ
Int J Parasitol; 2004 Oct; 34(11):1245-54. PubMed ID: 15491587
[TBL] [Abstract][Full Text] [Related]
16. A focused small-molecule screen identifies 14 compounds with distinct effects on Toxoplasma gondii.
Kamau ET; Srinivasan AR; Brown MJ; Fair MG; Caraher EJ; Boyle JP
Antimicrob Agents Chemother; 2012 Nov; 56(11):5581-90. PubMed ID: 22908155
[TBL] [Abstract][Full Text] [Related]
17. Age-Dependent Effects of ALK5 Inhibition and Mechanism of Neuroprotection in Neonatal Hypoxic-Ischemic Brain Injury.
Kim BH; Guardia Clausi M; Frondelli M; Nnah IC; Saqcena C; Dobrowolski R; Levison SW
Dev Neurosci; 2017; 39(1-4):338-351. PubMed ID: 28628913
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis reveals Toxoplasma gondii strain-specific differences in host cell response to dense granule protein GRA15.
Liu Q; Gao WW; Elsheikha HM; He JJ; Li FC; Yang WB; Zhu XQ
Parasitol Res; 2018 Sep; 117(9):2785-2793. PubMed ID: 29916065
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of
Fu Y; Cui X; Fan S; Liu J; Zhang X; Wu Y; Liu Q
mBio; 2018 Oct; 9(5):. PubMed ID: 30352931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
